Insulin-Induced Microvascular Activity in Patients With Essential Hypertension: a Possible Role for Angiotensin II AT1-Receptor Blockers.

Trial Profile

Insulin-Induced Microvascular Activity in Patients With Essential Hypertension: a Possible Role for Angiotensin II AT1-Receptor Blockers.

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 23 Jul 2015

At a glance

  • Drugs Irbesartan (Primary) ; Felodipine
  • Indications Essential hypertension
  • Focus Pharmacodynamics
  • Most Recent Events

    • 24 Sep 2010 Results presented at the 46th Annual Meeting of the European Association for the Study of Diabetes
    • 02 May 2009 New source identified and integrated (Netherlands Trial Register NTR1202).
    • 04 Feb 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top